Compare MDXH & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXH | JYNT |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | | Multi-Sector Companies |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 120.7M |
| IPO Year | 2021 | 2014 |
| Metric | MDXH | JYNT |
|---|---|---|
| Price | $2.29 | $8.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $7.67 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 210.3K | 32.2K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 133.93 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $117,696,356.00 |
| Revenue This Year | $30.78 | $12.23 |
| Revenue Next Year | $18.31 | N/A |
| P/E Ratio | ★ N/A | $45.71 |
| Revenue Growth | N/A | ★ 15.49 |
| 52 Week Low | $1.67 | $7.50 |
| 52 Week High | $5.33 | $13.47 |
| Indicator | MDXH | JYNT |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 47.53 |
| Support Level | $1.93 | $8.46 |
| Resistance Level | $2.75 | $9.47 |
| Average True Range (ATR) | 0.18 | 0.33 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 80.54 | 19.89 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.